Tag: #Global Trends

Pharmaceutical giant AstraZeneca has significantly expanded its partnership with Niowave, securing a decade-long supply of Actinium-225 (Ac-225) to bolster its... Read more

A Baltimore court has issued an unprecedented ruling against Johnson & Johnson (J&J), awarding $1.56 billion to a single plaintiff—the... Read more

Boehringer Ingelheim has unveiled a strategic partnership with Rectify Pharmaceuticals to develop small-molecule therapies that enhance the function of the... Read more

Medical technology firm Hologic has released new experimental data strengthening the role of artificial intelligence (AI) in breast cancer screening.... Read more

As of December 22, 2025, AstraZeneca has officially ceased all production and commercial sales of Andexxa in the United States.... Read more

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has officially granted marketing authorization for lenacapavir (branded as Yeytuo) for... Read more

The healthcare industry has reached a significant milestone with the FDA's official approval of the tablet version of semaglutide (Wegovy).... Read more

In a major step toward implementing the "Most-Favored-Nation" (MFN) pricing policy, the Trump administration has announced individual agreements with nine... Read more

Samsung Biologics has secured a $280 million deal to acquire GSK’s manufacturing facilities located in Rockville, Maryland. This strategic move... Read more